News

Insights from the 2024 Pharmacy Benefit Manager Satisfaction Report

Insights from the 2024 Pharmacy Benefit Manager Satisfaction Report

An Overview of the 2024 Pharmacy Benefit Manager Satisfaction Report

The 2024 Pharmacy Benefit Manager Customer Satisfaction Report, released by Pharmaceutical Strategies Group (PSG), offers critical insights into how satisfied healthcare payers are with their Pharmacy Benefit Managers (PBMs). This report serves as an essential tool for anyone interested in improving services within this intricate field.

Current Trends Among Healthcare Payers

This detailed analysis uncovers the current challenges faced by PBMs and healthcare payers. It sheds light on a growing trend of dissatisfaction among payers, who are increasingly advocating for change in the industry. The findings from the report underscore the urgent necessity for innovative models that can better cater to the varied needs of these organizations.

Decline in Satisfaction Rates

A major takeaway from the report is the troubling drop in satisfaction among healthcare payers. The likelihood of recommending PBMs is on the decline, as evidenced by a significant drop in the Net Promoter Score (NPS) from 38 in 2021 to just 6 in 2024. This decline suggests a shift in how payers view the effectiveness of current PBM practices and raises important questions regarding their functionality.

Employer vs. Health Plan Satisfaction

The report reveals that employers tend to have higher satisfaction levels with their PBMs compared to health plans. This gap suggests that while some payers find value in their arrangements, others are facing challenges in meeting expectations. Understanding these disparities could reveal best practices as well as areas that require improvement.

Insights into Payer Requirements

According to PSG, the obstacles payers encounter are complex, particularly when it comes to high-cost therapies and the need for transparency in pricing. Reports from various healthcare sectors consistently indicate a pressing demand for better models to provide pharmacy benefits that are both affordable and of excellent quality.

Industry Calls for Change

Morgan Lee, PhD, MPH, CPH, who serves as the Senior Director of Research & Strategy at PSG, notes that there is a clear and growing demand for transformation within the industry. The current report spotlights the barriers that exist and the hesitations that prevent PBM services from progressing. Nevertheless, a strong theme suggests that there is a widespread desire for change, indicating that the industry may be on the verge of significant transformation.

Insights on the Major Three PBMs

Interestingly, clients using the three largest PBMs report lower satisfaction levels, further emphasizing the critical need for enhancements across the board. Such insights are crucial for decision-makers eager to improve their relationships with PBMs and drive positive changes within their organizations.

About Pharmaceutical Strategies Group (PSG)

Pharmaceutical Strategies Group, part of EPIC, specializes in helping clients navigate the complexities of managing drug costs. PSG positions itself as a strategic partner, equipping healthcare payers with industry knowledge and technological solutions aimed at optimizing pharmacy programs. This focus on innovation allows clients to achieve significant savings on drug costs each year, affirming PSG's standing as a leader in this space.

Frequently Asked Questions

What is the main focus of the 2024 Pharmacy Benefit Manager Satisfaction Report?

This report centers on the satisfaction of healthcare payers with their PBMs and emphasizes the pressing need for change within the industry.

Why are healthcare payers dissatisfied with PBMs?

The dissatisfaction arises from a lack of effective models that adequately meet the varied needs of payers, as demonstrated by the declining satisfaction metrics in the report.

How has the Net Promoter Score changed over the years?

The Net Promoter Score for PBMs has seen a dramatic decrease, falling from 38 in 2021 to a mere 6 in 2024. This indicates a significant drop in the willingness to recommend these services.

What role does PSG play for healthcare payers?

PSG aids healthcare payers by offering strategic insights and tools that enhance the management of pharmacy programs, ultimately helping them achieve cost savings.

What does the future hold for PBMs according to the report?

Despite the clear dissatisfaction with current PBM models, there appears to be a strong desire for transformation, suggesting that changes are likely to occur soon.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 158

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading
Cybersecurity's AI Tailwind Meets a Brutal Market Test

Updated Category News Views 89

Security software caught a bid while the rest of the tape was getting kicked down the stairs. That contrast is the whole story: investors saw Palo Alto Networks deliver a strong fiscal first quarter and raise its fiscal 2027 outlook, then decided cyber defense may be one of the few technology budgets companies cannot casually postpone. With AI helping attackers locate and...

Continue Reading
IT Tech Packaging's Going-Concern Warning Lands Hard

Updated Category News Views 91

A paper maker can survive plenty of ugly quarters; it cannot casually shrug off an auditor questioning whether it can keep operating. That is the cold part of IT Tech Packaging's Nov. 19 disclosure. Its newly filed Form 10-K for the year ended Dec. 31, 2025 carries a “Material Uncertainty Related to Going Concern” paragraph from Audit Alliance LLP. Nobody should dress...

Continue Reading
AltaPointe PATH Outreach Puts Housing Waits in Focus

Updated Category News Views 128

Two years is a brutal length of time to ask somebody without stable housing to wait for an income-based apartment. That number hangs over AltaPointe Health's PATH program in Mobile, Alabama, and it ought to. The organization helped 16 people secure permanent housing in the past fiscal year, a figure that can look small if somebody is just skimming a report. It looks very...

Continue Reading
AT&T's Dec. 8 UBS Chat Puts Stankey's Updates on Watch

Updated Category News Views 202

A Small Slot With a Big Audience A calendar entry can still matter when the man holding the microphone runs AT&T. John Stankey, AT&T chairman and chief executive, is scheduled for a fireside chat at the UBS Global Media and Communications Conference on Tuesday, Dec. 8, beginning at 8:15 a.m. Eastern time. The company says the event will be webcast live through its...

Continue Reading
BET's HBCU Basketball Bet Is Bigger Than Six Games

Updated Category News Views 46

December television usually hands the microphone to the same old basketball machinery, which makes BET putting HBCU hoops in primetime feel overdue rather than merely promotional. Beginning December 3 at 8:00 p.m. ET, BET and Straight Shooter Media will air a six-game series built around Howard University and a rotating slate of opponents. The opener is Grambling State...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 0

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
Story Cannabis Bets on Neighborly Thanksgiving Outreach

Updated Category News Views 39

A frozen turkey is not a grand strategy deck, thank goodness; it is dinner for a household that might be feeling the squeeze. Story Cannabis plans to hand out 840 of them on Tuesday, Nov. 24, splitting the giveaway between Columbus and Cleveland with former Ohio State and Dallas Cowboys running back Michael Wiley joining employees and volunteers. In a cannabis business...

Continue Reading
PinnacleQM Makes Its Enterprise Case More Visible

Updated Category News Views 118

Six pages were never going to carry the weight of a complicated enterprise pitch. PinnacleQM has rebuilt its public face from a basic brochure into a library of more than 50 pages, putting its quality engineering, testing, automation and AI assurance work in clearer view for Australian technology and business buyers. This is not the sort of announcement that changes a...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 77

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading

Top 5 Most Recently Viewed Articles

BD Settles SEC Investigation While Strengthening Operations

Updated Category News Views 215

BD Reaches Settlement with the SEC BD (Becton, Dickinson and Company) (NYSE: BDX), a renowned leader in medical technology, has announced a significant agreement to resolve an investigation by the U.S. Securities and Exchange Commission (SEC). This follows concerns regarding prior public disclosures related to the BD Alaris™ System. Key Details of the Resolution The...

Continue Reading
Seizing the Managed Detection and Response Market Opportunity

Updated Category News Views 232

Unlocking the Managed Detection and Response Market Potential Middleton, Massachusetts – QKS Group, a leading market intelligence and advisory firm, recently released an insightful report on the global Managed Detection and Response (MDR) Market. This comprehensive analysis targets industry leaders eager to tap into a rapidly growing sector. According to their findings,...

Continue Reading
Expanding Horizons: Coldwell Banker's Venture into Africa

Updated Category News Views 94

Coldwell Banker Real Estate's New Milestone Coldwell Banker Tanzania and Zanzibar have officially joined the growing network of Coldwell Banker Real Estate LLC, marking an exciting expansion into Africa. This new master franchise embodies the brand’s ongoing commitment to deliver top-tier real estate services on an international scale. Seizing Growing Markets The real...

Continue Reading
Automotive Grade Linux Unveils SoDeV Platform for Advancements

Updated Category News Views 289

Automotive Grade Linux Introduces SoDeV for Software Defined Vehicles In an exciting development for the automotive industry, Automotive Grade Linux (AGL) has launched SoDeV, an open-source reference platform aimed at significantly enhancing the development of Software Defined Vehicles (SDVs). This innovative platform allows developers to focus on software-first...

Continue Reading
Exploring Promising Tech Stocks Ahead of Future Opportunities

Updated Category News Views 257

Opportunity in Oversold Tech Stocks The information technology sector is witnessing a notable shift, with several stocks currently considered undervalued. These oversold stocks represent potential opportunities for savvy investors looking to capitalize on future growth. By focusing on these stocks, investors can identify undervalued companies that have the potential for...

Continue Reading